The information on this page was last updated on 26 April 2023.

The Company’s shares are only traded on the London Stock Exchange’s AIM market at present.

The number of shares in issue is 194,129,426 ordinary shares of 10p each. No ordinary shares are held as treasury shares and therefore the total number of voting rights in the Company is 194,129,426.

There are no restrictions on the transfer of securities.

As far as the Company is aware, the percentage of the Company’s issued share capital not in public hands (as defined by the AIM Rules for Companies) is 12.07%.

In so far as the Company has been notified, the Company’s significant (3% or larger) shareholders are as follows.

Name

Number of shares

% of total ISC

Stonehage Fleming Investment Management Ltd 21,560,000

11.03%

Richard Sneller

18,927,500

9.75%

Columbia Threadneedle Investments

11,532,834

5.94%

Liontrust Investment Partners LLP

9,572,615

4.93%

David and Monique Newlands

9,969,600

5.10%

Canaccord Genuity Wealth Management

8,705,805 4.65%

Premier Miton Group plc

8,529,969

4.39%

 

Directors’ shareholdings

Name

Number of shares

% of total ISC

Mr John McMullan, Medical Director

2,944,966 1.51%
Professor Prasad Godbole, Group Chief Operating Officer (non-board) 2,928,062

1.50%

Mr Robert Holt OBE (Chairman)

1,500,000

0.76%

Mrs Wendy Lawrence, Chief Executive Officer

872,965

0.45%

Mrs Lisa Barter, Finance Director

688,639

0.35%

Mr Mike Rogers, Non-Executive Director

260,000

0.13%

Mr Tony Bourne, Non-Executive Director

161,000

0.08%

Mr John Charlton, Company Secretary

113,173

0.06%

 

For all shareholder enquiries please contact John Charlton, Group Company Secretary, at john.charlton@totallyplc.com